Marker Therapeutics Inc
MRKR
Get informed when a big investor buys or sells
+ FollowMarket Cap$23.18M
Close$
Compare to Similar Companies
| P/E Ratio | Dividends | Return on Equity | Price-to-Sales | Debt-to-Equity | ||
|---|---|---|---|---|---|---|
| Marker Therapeutics Inc | -2.9 | - | -99984814% | - | - | |
$1.05
31% downside
Current Fair Value
31% downsideOvervalued by 31% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $23.18 Million |
|---|---|
| Enterprise Value | $12.44 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.79 |
| Beta | 1.51 |
| Outstanding Shares | 19,314,742 |
Return
| Return on Equity | -99984813.93% |
|---|---|
| Return on Assets | -83395351.91% |
| Return on Invested Capital | -105959162.95% |
Valuation & Multiples
| P/E Ratio | -2.9 |
|---|---|
| PEG | 5.31 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 5.32 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
$694,000
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$2.12 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 20.55%▲ 0.35% |
|---|---|
| Total Invested | $5.84M▲ 15.02% |
| Investors Holding | 35▼ 1.00% |
ESG Score
No data
About Marker Therapeutics Inc
CEO: Peter Hoang